menu
    • menu

    Company profile for Radius Health

    NEW Drugs in Dev: 7
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Radius is a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine therapeutics. Radius’ lead product, TYMLOS® (abaloparatide) injection, was approved by the U.S. Food and Drug Administration for the treatment of postmenopausal women with osteoporosis at high risk for fracture. The Radius clinical pipeline includes investigational abaloparatide i...
    Radius is a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine therapeutics. Radius’ lead product, TYMLOS® (abaloparatide) injection, was approved by the U.S. Food and Drug Administration for the treatment of postmenopausal women with osteoporosis at high risk for fracture. The Radius clinical pipeline includes investigational abaloparatide injection for potential use in the treatment of men with osteoporosis; an investigational abaloparatide patch for potential use in the treatment of postmenopausal women with osteoporosis.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Radius HealthUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    950 Winter Street Waltham, MA 02451
    Telephone
    Telephone
    617-551-4000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://radiuspharm.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/radius-health-inc/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Radius_Health

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    B-FLEXION Life Acquires Remaining 57% Stake In Radius Health
    B-FLEXION Life Acquires Remaining 57% Stake In Radius Health

    12 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/b-flexion-life-sciences-to-acquire-remaining-57-interest-in-radius-health-302658260.html

    PR NEWSWIRE
    12 Jan 2026
    Share Share
    Radius Pharma Signs Agreement with Pharmanovia for Abaloparatide
    Radius Pharma Signs Agreement with Pharmanovia for Abaloparatide

    02 Jan 2025

    // ACCESSWIRE

    https://www.accesswire.com/962075/radius-pharmaceuticals-announces-licensing-agreement-with-pharmanovia-to-register-and-commercialize-abaloparatide-in-china-and-select-asia-pacific-territories

    ACCESSWIRE
    02 Jan 2025
    Share Share
    Radius Pharma Expands Abaloparatide Licensing Agreement
    Radius Pharma Expands Abaloparatide Licensing Agreement

    09 Dec 2024

    // ACCESSWIRE

    https://www.accesswire.com/951473/radius-pharmaceuticals-expands-abaloparatide-licensing-agreement-with-theramex-granting-additional-commercialization-rights-including-mexico-canada-south-africa-israel-and-russia

    ACCESSWIRE
    09 Dec 2024
    Share Share
    Neupath Health to be Featured On Radius Research Webinar
    Neupath Health to be Featured On Radius Research Webinar

    21 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241020898766/en

    BUSINESSWIRE
    21 Oct 2024
    Share Share
    US FDA grants approval for Radius’ Tymlos for osteoporosis in men
    US FDA grants approval for Radius’ Tymlos for osteoporosis in men

    22 Dec 2022

    // PHARMACEUTICAL-TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/fda-radius-tymlos-osteoporosis/

    PHARMACEUTICAL-TECHNOLOGY
    22 Dec 2022
    Share Share
    EU Moment of Truth For Abaloparatide & Advanced Therapy Tab-Cel
    EU Moment of Truth For Abaloparatide & Advanced Therapy Tab-Cel

    11 Oct 2022

    // PHARMAINTELLIGENCE

    https://pink.pharmaintelligence.informa.com/PS147138/EU-Moment-of-Truth-For-Abaloparatide--Advanced-Therapy-TabCel

    PHARMAINTELLIGENCE
    11 Oct 2022
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search